Growing Expectations for 'Vaccine Partnership Building'
Strengthening Alliances and Preparing Solutions for North Korea in Order

On the 21st (local time), at the first summit meeting between President Moon Jae-in and U.S. President Joe Biden held in the United States, our citizens showed the greatest expectations for achievements related to the ‘vaccine.’ This reflects public opinion hoping for the swift resolution of concerns regarding vaccine supply. In this context, the U.S. raised the possibility of a ‘vaccine swap’ by announcing overseas vaccine support measures four days ahead of the Korea-U.S. summit.


[AKYUNG Poll] 45% of People Say "Vaccine Decision at Hanmi Summit" View original image


According to a survey conducted by Asia Economy through Win-G Korea Consulting from the 15th to 16th among 1,019 men and women nationwide aged 18 and over, 45.0% of respondents cited ‘establishing a partnership related to COVID-19 vaccines’ as the most anticipated outcome of the Korea-U.S. summit. The proportion who answered ‘strengthening the Korea-U.S. alliance system’ was 28.5%, and ‘finding a solution to the North Korean nuclear issue’ was 19.2%. Those who answered ‘don’t know’ accounted for 7.4%.


Across all age groups, the proportion selecting ‘establishing a partnership related to COVID-19 vaccines’ exceeded 40%, especially among those in their 20s (46.6%), 30s (46.7%), and 40s (47.6%), surpassing the overall average. By gender, women (49.9%) had higher expectations for vaccine achievements than men (40.0%), and by region, Daegu and Gyeongbuk recorded the highest at 50.2%.


While national critical issues such as the Korea-U.S. alliance and the North Korean nuclear problem are important, the strong call for achievements in the ‘vaccine’ sector indicates significant domestic anxiety about vaccine supply. In this regard, President Moon stated on the 17th, “We will strengthen vaccine cooperation and take this as an opportunity to become a global hub for vaccine production.” It is expected that the Korea-U.S. summit will focus on discussing a ‘vaccine swap’ method, where the U.S. provides surplus vaccines to Korea, which will be repaid later. On the 17th (local time), four days before the summit, President Biden announced in a speech that 20 million doses of three vaccines produced domestically?Pfizer, Moderna, and Janssen?would be provided to other countries by the end of June.


President Moon will make an official working visit to Washington from the 19th to the 22nd at President Biden’s invitation. Scheduled events include a visit to Arlington National Cemetery and a meeting with the Speaker of the U.S. House of Representatives on the 20th. On the 21st, meetings with the U.S. Vice President and the Korea-U.S. summit will take place, followed by a joint press conference immediately after the summit. On the afternoon of the 22nd, he plans to travel to Atlanta to visit the SK Innovation plant, a local business operation.



This public opinion survey was conducted using 100% automated response system (ARS) with virtual mobile phone numbers, weighted by gender, age, and region. The response rate was 8.0%, and the sampling error was ±3.1 percentage points at a 95% confidence level. Detailed survey information can be found on the Win-G Korea Consulting website or the Central Election Survey Deliberation Commission website.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing